Is Stryker Corporation (NYSE:SYK) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Stryker Corporation at current levels.
Mako is becoming the standard, not the upgrade. The robot installed base is the moat everyone underestimates.
Where SYK is headed
By 2028, the question won't be whether Stryker sells robots to hospitals. It'll be whether any major joint replacement happens without one. Mako already drives over half of US knee procedures at customer sites, and the shoulder application launched in 2024 is doing to that segment what the knee version did a decade ago. The spine and revision knee indications coming through clinical work now extend the platform into procedures that represent another $8B in annual implant pull-through. Each robot Stryker plants in a hospital is a 15-year annuity on consumables, single-use instruments, and locked-in implant choice. That's the real business hiding behind a 2.6% reported growth print that includes FX drag and a heavy acquisition integration year.
Read the full Compass Direction on SYK
The complete destination call, the overlooked angle, milestones, and bull, base, and bear price scenarios.
See the full SYK analysisGet calls like this, free
Join the Alexandria e-letter for forward-looking verdicts, earnings intelligence, and the contrarian reads the crowd misses. Twice a week, no noise.
Free forever. Unsubscribe anytime. We never share your email.
Frequently asked questions
Is Stryker Corporation (NYSE:SYK) a buy in 2026?
Yes, on balance. The Compass leans toward accumulating Stryker Corporation at current levels. Mako is becoming the standard, not the upgrade. The robot installed base is the moat everyone underestimates.
What is SYK's Compass Score?
Stryker Corporation scores 74/100 on Alexandria's Compass, placing it in the "Favorable" tier. Scores blend eight factors and update weekly.
What is the price target for SYK?
Alexandria's full Compass Direction includes bull, base, and bear price scenarios with the valuation math behind each. Read the full breakdown on the SYK page.
Compass verdicts are AI-generated, forward-looking editorial research from publicly available data, not investment advice or a recommendation regarding any security. Scores and verdicts update as the data changes.